[go: up one dir, main page]

BR9913348A - Tratamento dos distúrbios da ansiedade - Google Patents

Tratamento dos distúrbios da ansiedade

Info

Publication number
BR9913348A
BR9913348A BR9913348-2A BR9913348A BR9913348A BR 9913348 A BR9913348 A BR 9913348A BR 9913348 A BR9913348 A BR 9913348A BR 9913348 A BR9913348 A BR 9913348A
Authority
BR
Brazil
Prior art keywords
treatment
anxiety disorders
mammal
administering
prevention
Prior art date
Application number
BR9913348-2A
Other languages
English (en)
Inventor
Lee Alan Phebus
Tammy Joy Sajdyk
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9913348A publication Critical patent/BR9913348A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção: <B>"TRATAMENTO DOS DISTúRBIOS DA ANSIEDADE"<D>. A presente invenção proporciona um método para o tratamento ou a prevenção dos distúrbios da ansiedade que consiste na administração a um mamífero necessitando de tal tratamento de um antagonista do receptor da serotonina 5-HT~ 1F~.
BR9913348-2A 1998-07-27 1999-07-08 Tratamento dos distúrbios da ansiedade BR9913348A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9431098P 1998-07-27 1998-07-27
PCT/US1999/015475 WO2000006082A2 (en) 1998-07-27 1999-07-08 Treatment of anxiety disorders

Publications (1)

Publication Number Publication Date
BR9913348A true BR9913348A (pt) 2001-06-12

Family

ID=22244420

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913348-2A BR9913348A (pt) 1998-07-27 1999-07-08 Tratamento dos distúrbios da ansiedade

Country Status (14)

Country Link
EP (1) EP0976747A3 (pt)
JP (1) JP2003527305A (pt)
KR (1) KR20010072064A (pt)
CN (1) CN1315830A (pt)
AU (1) AU4977899A (pt)
BR (1) BR9913348A (pt)
CA (1) CA2338740A1 (pt)
EA (1) EA200100182A1 (pt)
HU (1) HUP0102886A3 (pt)
IL (1) IL140540A0 (pt)
NO (1) NO20010390L (pt)
PL (1) PL366197A1 (pt)
TR (1) TR200100240T2 (pt)
WO (1) WO2000006082A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60010758T2 (de) * 1999-12-20 2005-05-12 Eli Lilly And Co., Indianapolis Piperidin-derivate und ihre verwendung als serotonin rezeptor antagonisten
EP1242411B1 (en) 1999-12-20 2006-03-08 Eli Lilly And Company Indole derivatives for the treatment of depression and anxiety
US6844344B2 (en) 1999-12-20 2005-01-18 Eli Lilly And Company Benzofuran derivatives
EP1853577A4 (en) * 2005-02-17 2009-02-18 Bayer Cropscience Ag IMPROVED PROCESS FOR THE PREPARATION OF (DISUBSTITUTED PROPENYL) PHENYL ALKYL SUBSTITUTED DIHYDROBENZOFURANES
EP1853614A4 (en) * 2005-02-17 2008-06-25 Bayer Cropscience Ag IMPROVED METHOD FOR THE SYNTHESIS OF GROUP-SUBSTITUTED DIHYDROBENZOFURANES (PHENYLALKYL DISUBSTITUTED PROPENYL)
JP2008534507A (ja) * 2005-03-23 2008-08-28 バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト 殺虫活性を有する（二置換プロペニル）フェニルアルキル置換ジヒドロベンゾフランを調製するための改善された方法
CN107973766B (zh) * 2016-10-21 2020-06-19 石家庄诚志永华显示材料有限公司 含有环烷基的氧芴衍生物的液晶化合物及其应用
TWI744458B (zh) * 2017-02-27 2021-11-01 日商捷恩智股份有限公司 具有二苯并呋喃環的化合物、液晶組成物及液晶顯示元件

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2941597A1 (de) * 1979-10-13 1981-04-23 Basf Ag, 6700 Ludwigshafen Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5698571A (en) * 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
US5521197A (en) * 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists

Also Published As

Publication number Publication date
TR200100240T2 (tr) 2002-01-21
JP2003527305A (ja) 2003-09-16
WO2000006082A3 (en) 2000-05-04
NO20010390L (no) 2001-03-13
PL366197A1 (en) 2005-01-24
EP0976747A3 (en) 2000-09-13
EA200100182A1 (ru) 2001-08-27
WO2000006082A2 (en) 2000-02-10
IL140540A0 (en) 2002-02-10
HUP0102886A2 (en) 2002-06-29
CN1315830A (zh) 2001-10-03
AU4977899A (en) 2000-02-21
CA2338740A1 (en) 2000-02-10
HUP0102886A3 (en) 2002-12-28
KR20010072064A (ko) 2001-07-31
EP0976747A2 (en) 2000-02-02
NO20010390D0 (no) 2001-01-23

Similar Documents

Publication Publication Date Title
BR9814923A (pt) Método para tratamento de doença de alzheimer
BR9914901A (pt) Agonistas do receptor 5ht1 e metoclopramida para o tratamento de enxaqueca
BR0013122A (pt) Ciclobenzaprina para tratamento de distúrbio de ansiedade generalizado e composições de ciclobenzaprina
BRPI0410746A (pt) compostos e composições imunossupressoras
DE69017302D1 (de) Zentrale Cholecystokinin-Antagonisten zur Behandlung von psychiatrischen Krankheiten.
BRPI0414435A (pt) métodos e reagentes para o tratamento de distúrbios imunoinflamatórios
BRPI0415657A (pt) derivados de alcanamina de diidrobenzofuranila como agonistas de 5ht2c
ATE348829T1 (de) Pharmazeutische zusammensetzungen zur behandlung von störungen des zns oder anderen erkrankungen
BR9909138A (pt) Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda
BR0007556A (pt) Antagonistas de tweak e de receptor de tweak e uso dos mesmos para tratar distúrbios imunológicos
BR0114410A (pt) Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade
BR0109966A (pt) Combinação de compostos orgânicos
BR9911779A (pt) Benzotiofenos, benzofuranos e indóis úteis no tratamento de resistência à insulina e hiperglicemia
BR9913319A (pt) Composições e métodos para tratamento de doenças mitocondriais
BR0313624A (pt) Agonismo do receptor 5ht2a para tratamento da disfunção termo-regulatória
BR0104830A (pt) Tratamento de combinação para a demência ou déficits cognitivos associados com a doença de alzheimer e com a doença de parkinson
DK1461318T3 (da) Tetrahydroquinolinanaloge som muscariniske agonister
BR9811093A (pt) Piridinas substituìdas com 2-amino-6-(4-fenóxi 2-substituìdo)
BR0207802A (pt) Uso de agonistas inversos de gabaa em combinação com agonistas parciais do receptor de nicotina, estrogênios, moduladores de estrogênio seletivos, ou vitamina e para o tratamento de distúrbios cognitivos
BRPI0412919A (pt) combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos
YU7699A (sh) Lečenje prehlade ili alergijskog rinitisa
BR0010380A (pt) Método, composição farmacêutica, kit e uso de uma combinação para prevenção e tratamento de diversas disfunções tromboembólicas e métodos de tratamento de trombose em mamìferos
BR9913348A (pt) Tratamento dos distúrbios da ansiedade
BR0110208A (pt) Composições e terapias para distúrbios associados com hiperlipidemia
BR0011578A (pt) Utilização do s-enantiÈmero de citalopram para tratamento de distúrbio de ansiedade geral ou ataques de pânico

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]